PALO ALTO, Calif., July 6 /PRNewswire-FirstCall/ -- Management from Varian Medical Systems, Inc. (NYSE: VAR) are scheduled to participate in the Piper Jaffray Cancer Summit on July 14, at the Piper Jaffray headquarters in Minneapolis.
Participating executives will include: Dow Wilson, executive vice president and president of Varian's Oncology Systems business; Lester Boeh, vice president for emerging businesses and head of Varian's Particle Therapy group; and Spencer Sias, vice president of corporate communications and investor relations. They are expected to participate in panel discussions on stereotactic radiosurgery and on proton therapy.
Varian Medical Systems, Inc., of Palo Alto, California, is the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy, and brachytherapy. The company supplies informatics software for managing comprehensive cancer clinics, radiotherapy centers and medical oncology practices. Varian is a premier supplier of tubes and digital detectors for X-ray imaging in medical, scientific, and industrial applications and also supplies X-ray imaging products for cargo screening and industrial inspection. Varian Medical Systems employs approximately 5,100 people who are located at manufacturing sites in North America, China and Europe and in its 79 sales and support offices around the world. For more information, visit http://www.varian.com/.
FOR INFORMATION CONTACT:
Spencer Sias, (650) 424-5782
Vice President, Corporate Communications
and Investor Relations
SOURCE Varian Medical Systems, Inc.